(Q33344576)

26 July 2017

A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancer (English)

1 reference

26 July 2017

1 reference

1 reference

Sumeet Bhatia

1

1 reference

26 July 2017

Nasser Hanna

2

1 reference

26 July 2017

Rafat Ansari

3

1 reference

26 July 2017

William Pletcher

4

1 reference

26 July 2017

Lawrence Einhorn

5

1 reference

26 July 2017

Elizabeth Ng

6

1 reference

26 July 2017

Alan Sandler

7

1 reference

26 July 2017

language of work or name

1 reference

1 October 2002

1 reference

26 July 2017

1 reference

26 July 2017

38

1 reference

26 July 2017

73-77

1 reference

26 July 2017

1

1 reference

26 July 2017

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900145-9

7 January 2021

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900145-9

7 January 2021

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900145-9

7 January 2021

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900145-9

7 January 2021

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900145-9

7 January 2021

Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900145-9

7 January 2021

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900145-9

7 January 2021

Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900145-9

7 January 2021

Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900145-9

7 January 2021

Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non--small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900145-9

7 January 2021

Trimodality therapy in stage III non-small cell lung cancer: prediction of recurrence by assessment of p185neu

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900145-9

7 January 2021

10.1016/S0169-5002(02)00145-9

Identifiers

DOI

1 reference

26 July 2017

1 reference